THYTECH
This profile has not been verified by the business owner.
Information may be incomplete or outdated.
#Inmunología
#Terapias Celulares avanzadas
#Investigación Biomédica
Overview
THYTECH is a spin-off of the Gregorio Marañón Health Research Institute (IISGM) that was created with the aim of transferring to the patient our patented technology for the treatment of diseases related to immune disorders.
The company arises from the work carried out by the researchers of the Immunoregulation Laboratory, and our main asset is a cellular therapy with thyTreg cells that is pioneering in the world that can establish a new paradigm in the prevention of transplant rejection and in the treatment of autoimmune diseases and clinical worsening of COVID patients.
Contact Details
info@thytech.com
Madrid, Spain
Founded
2022
Employees
2-10
Categories
Keywords
#Inmunología
#Terapias Celulares avanzadas
#Investigación Biomédica
Companies teams usually look at after THYTECH
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.